Market closedNon-fractional

SpringWorks/SWTX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About SpringWorks

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Ticker

SWTX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Stamford, United States

Employees

305

SpringWorks Metrics

BasicAdvanced
$2.8B
Market cap
-
P/E ratio
-$5.14
EPS
0.83
Beta
-
Dividend rate
$2.8B
0.83
6.846
6.56
0.984
1.156
-36.63%
-63.12%
92.97
4.86
4.86
-10.04
0.69%
-8.91%
56.62%

What the Analysts think about SpringWorks

Analyst Ratings

Majority rating from 8 analysts.
Buy

SpringWorks Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-415.71% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$21M
288.89%
Net income
-$87M
-7.42%
Profit margin
-415.71%
-76.19%

SpringWorks Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.71%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.25
-$1.27
-$1.45
-$1.18
-
Expected
-$1.26
-$1.33
-$1.24
-$1.17
-$1.12
Surprise
-0.95%
-4.51%
16.89%
0.71%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for SpringWorks stock?

SpringWorks (SWTX) has a market cap of $2.8B as of July 04, 2024.

What is the P/E ratio for SpringWorks stock?

The price to earnings (P/E) ratio for SpringWorks (SWTX) stock is 0 as of July 04, 2024.

Does SpringWorks stock pay dividends?

No, SpringWorks (SWTX) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next SpringWorks dividend payment date?

SpringWorks (SWTX) stock does not pay dividends to its shareholders.

What is the beta indicator for SpringWorks?

SpringWorks (SWTX) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell SpringWorks stock

Buy or sell SpringWorks stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing